. . . . . . . . "Abrogates interaction with RAD51; when associated with A-317. Reduces phosphorylation and impairs activation by hydroxyurea and ionizing radiation. Impairs interaction with YWHAZ which is required for nuclear retention after checkpoint activation." . "345"^^ . . "345"^^ . . . . . . "Enhances interaction with RAD51; when associated with E-317." . "345"^^ . . "345"^^ . . "Mutagenesis site occurs in NX_O14757-1 at amino acids 345 - 345." . . . . . . "neXtProt gold" . . . . . . . . . . . . . "2014-09-19T00:00:00.0Z"^^ . . . "neXtProt database" . "CALIPHO project" . . . . . "2" . . . . .